Human Papillomavirus (HPV) News and Research

Latest Human Papillomavirus (HPV) News and Research

Imaxio, DKFZ partner to evaluate potential of IMX313 with candidate vaccine targeting HPV

Imaxio, a biopharmaceutical company specialized in vaccines, today announces that it has signed an option for a license agreement with the world-renowned German Center for Cancer Research (DKFZ – Deutsches Krebsforschungszentrum), based in Heidelberg. The financial terms of the agreement were not disclosed.

15 Oct 2014

Tobacco use linked to oral HPV-16

Study participants who reported tobacco use or had higher levels of biomarkers of tobacco exposure had a higher prevalence of the sexually transmitted infection, oral human papillomavirus type 16 (HPV-16), according to a study in the October 8 JAMA, a theme issue on infectious disease.

8 Oct 2014

Penn Medicine to explore therapeutic strategies for HIV positive women at risk of cervical cancer

The introduction of antiretroviral drugs in Botswana over the last two decades has increased the life expectancies of people living with HIV—many of whom are women co-infected with the human papillomavirus virus (HPV)—considerably: from 39 years to the low 60s. As a result, this co-infected group of women is at a much higher risk of developing HPV-associated cervical cancer.

7 Oct 2014

Seven NIH research contracts awarded to identify novel adjuvant candidates

The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, has awarded seven research contracts to discover and characterize new adjuvants, or substances formulated as part of vaccines to enhance their protective ability.

30 Sep 2014

Montefiore-Einstein selected to conduct multi-site cancer clinical trials

Montefiore Einstein Center for Cancer Care and Albert Einstein College of Medicine of Yeshiva University have been awarded a $3.4 million grant from the National Cancer Institute to conduct multi-site cancer clinical trials and research focused on reducing healthcare disparities in cancer care.

29 Sep 2014

Cancer-fighting cocktail shows promising results for advanced cervical cancer

Combining a standard chemotherapy drug with a second drug that stops cells from dividing improves both the survival and response rates for those with advanced cervical cancer, a new study by UT Southwestern Medical Center cancer researchers finds.

16 Sep 2014

61% less cases of genital warts among women after introducing HPV vaccination program

GPs in Australia are managing 61 per cent less cases of genital warts among young women since the introduction of the national human papillomavirus (HPV) vaccination program, a new study from the University of Sydney reveals.

8 Sep 2014

Viewpoints: Employers and health benefits; Sen. Pryor's ACA endorsement; waging war on hep C

Most of the political class seems to have decided that ObamaCare is working well enough, the opposition is fading, and the subsidies and regulation are settling in as the latest wing of the entitlement state.

25 Aug 2014

Trovagene announces results from clinical studies on urine-based diagnostic test for detection of HPV

Trovagene, Inc., a developer of cell-free molecular diagnostics, announced today that results from two clinical studies will be presented at the 29th International Papillomavirus conference for the Company's urine-based diagnostic test for the detection of high risk strains of Human Papillomavirus.

20 Aug 2014

Research roundup: The effect of expensive cancer therapies; missed hospital handovers; children's mental health needs

Medicare uses more than a dozen different payment systems to set payment rates for the medical items and services the program covers for beneficiaries.

4 Aug 2014

Blood test can predict recurrence of HPV-linked oral cancers

Research published yesterday indicates that recurrence of human papillomavirus (HPV)-induced cancers affecting the oropharynx (the area of the throat just behind the mouth) can be predicted by blood and saliva tests that screen for DNA fragments from HPV that have been shed by cancer cells.

1 Aug 2014

Blood and saliva tests help accurately predict recurrences of HPV associated oral cancers

Physicians at Johns Hopkins have developed blood and saliva tests that help accurately predict recurrences of HPV-linked oral cancers in a substantial number of patients.

1 Aug 2014

Genticel provides update on patents granted in the USA and Asia

Genticel, a French biotechnology company and leading developer of therapeutic vaccines, provides an update on patents that have recently enriched its intellectual property estate.

25 Jul 2014

Uptake of HPV vaccine in US is unacceptably low

Data from the CDC's 2013 National Immunization Survey-Teen (NIS-Teen) published today show that the human papillomavirus (HPV) vaccine continues to be underutilized.

25 Jul 2014

HPV vaccination may be effective in reducing abnormal Pap test results even after sexual debut

Minority women who received the Human Papillomavirus Vaccination (HPV) even after becoming sexually active had lower rates of abnormal Pap test results than those who were never vaccinated.

25 Jul 2014

Advaxis, MedImmune team up for immuno-oncology clinical trial

Advaxis, Inc., a clinical-stage biotechnology company developing cancer immunotherapies, has entered into a clinical trial collaboration with MedImmune, the global biologics research and development arm of AstraZeneca.

23 Jul 2014

Study does not find association between HPV vaccination and increased risk of blood clot

Although some data has suggested a potential association between receipt of the quadrivalent human papillomavirus (HPV) vaccination and subsequent venous thromboembolism (VTE; blood clot), an analysis that included more than 500,000 women who received the vaccine did not find an increased risk of VTE, according to a study in the July 9 issue of JAMA.

8 Jul 2014

Survey shows biggest barrier to receiving Human Papillomavirus vaccine

A survey of first-year Grand Valley State University students showed the biggest barrier to receiving a Human Papillomavirus (HPV) vaccine was moral or religious beliefs, or a perceived promotion of sexual behavior, according to graduate physician assistant researchers.

8 Jul 2014

Adeno-associated virus type 2 kills triple-negative breast cancer cells in mice

A virus not known to cause disease kills triple-negative breast cancer cells and killed tumors grown from these cells in mice, according to Penn State College of Medicine researchers. Understanding how the virus kills cancer may lead to new treatments for breast cancer.

24 Jun 2014

Inovio evaluates responses of immunotherapy product in treating HPV linked head and neck cancer

Inovio Pharmaceuticals, Inc. (NYSE MKT: INO) today announced it has initiated a phase I/IIa clinical trial to evaluate safety, immunogenicity and clinical responses of its immunotherapy product, INO-3112, in treating human papillomavirus (HPV)- associated head and neck cancer.

10 Jun 2014

Human Papillomavirus (HPV) News and Research

Latest Human Papillomavirus (HPV) News and Research

Imaxio, DKFZ partner to evaluate potential of IMX313 with candidate vaccine targeting HPV

Tobacco use linked to oral HPV-16

Penn Medicine to explore therapeutic strategies for HIV positive women at risk of cervical cancer

Seven NIH research contracts awarded to identify novel adjuvant candidates

Montefiore-Einstein selected to conduct multi-site cancer clinical trials

Cancer-fighting cocktail shows promising results for advanced cervical cancer

61% less cases of genital warts among women after introducing HPV vaccination program

Viewpoints: Employers and health benefits; Sen. Pryor's ACA endorsement; waging war on hep C

Trovagene announces results from clinical studies on urine-based diagnostic test for detection of HPV

Research roundup: The effect of expensive cancer therapies; missed hospital handovers; children's mental health needs

Blood test can predict recurrence of HPV-linked oral cancers

Blood and saliva tests help accurately predict recurrences of HPV associated oral cancers

Genticel provides update on patents granted in the USA and Asia

Uptake of HPV vaccine in US is unacceptably low

HPV vaccination may be effective in reducing abnormal Pap test results even after sexual debut

Advaxis, MedImmune team up for immuno-oncology clinical trial

Study does not find association between HPV vaccination and increased risk of blood clot

Survey shows biggest barrier to receiving Human Papillomavirus vaccine

Adeno-associated virus type 2 kills triple-negative breast cancer cells in mice

Inovio evaluates responses of immunotherapy product in treating HPV linked head and neck cancer

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Human Papillomavirus (HPV) News and Research

Latest Human Papillomavirus (HPV) News and Research

Breathing New Life into Diagnostics: Plasmion's SICRIT Technology

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Newsletters you may be interested in